Drug Interactions of Clinical Importance with Antihyperglycaemic Agents
- 1 January 2005
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 28 (7) , 601-631
- https://doi.org/10.2165/00002018-200528070-00004
Abstract
Because management of type 2 diabetes mellitus usually involves combined pharmacological therapy to obtain adequate glucose control and treatment of concurrent pathologies (especially dyslipidaemia...Keywords
This publication has 233 references indexed in Scilit:
- Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and WomenArchives of internal medicine (1960), 2004
- NateglinideDrugs, 2000
- PioglitazoneDrugs, 2000
- MiglitolDrugs, 2000
- Implications of the UK Prospective Diabetes StudyDrugs & Aging, 2000
- ATP-sensitive K + channels and insulin secretion: their role in health and diseaseDiabetologia, 1999
- Drug Treatment of Non-Insulin-Dependent Diabetes Mellitus in the 1990sDrugs, 1997
- Clinical Pharmacokinetics of MetforminClinical Pharmacokinetics, 1996
- Comparative Tolerability Profiles of Oral Antidiabetic AgentsDrug Safety, 1994
- AcarboseDrugs, 1993